Cargando…
Pseudomonas aeruginosa PAO 1 In Vitro Time–Kill Kinetics Using Single Phages and Phage Formulations—Modulating Death, Adaptation, and Resistance
Pseudomonas aeruginosa is responsible for nosocomial and chronic infections in healthcare settings. The major challenge in treating P. aeruginosa-related diseases is its remarkable capacity for antibiotic resistance development. Bacteriophage (phage) therapy is regarded as a possible alternative tha...
Autores principales: | Pinto, Ana Mafalda, Faustino, Alberta, Pastrana, Lorenzo M., Bañobre-López, Manuel, Sillankorva, Sanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300829/ https://www.ncbi.nlm.nih.gov/pubmed/34356798 http://dx.doi.org/10.3390/antibiotics10070877 |
Ejemplares similares
-
Quorum Sensing Promotes Phage Infection in Pseudomonas aeruginosa PAO1
por: Xuan, Guanhua, et al.
Publicado: (2022) -
Characterization of MSlys, the endolysin of Streptococcus pneumoniae phage MS1
por: Silva, Maria Daniela, et al.
Publicado: (2020) -
Antibiofilm Efficacy of the Pseudomonas aeruginosa Pbunavirus vB_PaeM-SMS29 Loaded onto Dissolving Polyvinyl Alcohol Microneedles
por: Sillankorva, Sanna, et al.
Publicado: (2022) -
Phage Resistance Evolution Induces the Sensitivity of Specific Antibiotics in Pseudomonas aeruginosa PAO1
por: Xuan, Guanhua, et al.
Publicado: (2022) -
Emerging Phage Resistance in Pseudomonas aeruginosa PAO1 Is Accompanied by an Enhanced Heterogeneity and Reduced Virulence
por: Markwitz, Pawel, et al.
Publicado: (2021)